Mark is an Associate Professor in the Department of Medicine and the Center for Immunity and Inflammation at Rutgers New Jersey Medical School.
Mark received his PhD from Johns Hopkins University in Molecular, Microbiology and Immunology and did his Post doc at the University of Pennsylvania under David Artis.
Mark has published in multiple prestigious journals and has served as permanent member of the Innate Immunity and Inflammation NIH study section since 2022. Mark has been awarded multiple grants and currently holds 3 NIH R01s as a Principle Investigator.
Chief Executive Officer
Nick received his PhD from Brown University in Pathobiology and did his postdoc at Seattle Children’s Research Institute under Adrian Piliponsky, where he focused on understanding the roles of mast cells and basophils in acute inflammatory diseases. Nick has published research in journals such as Nature Immunology and Journal of Allergy and Clinical Immunology. Before joining NemaGen, Nick worked in Business Development for an immunoassay biotechnology company.